-
01-06-2023, 07:39 AM
#911
Member
Originally Posted by percy
Neither can I...
However I fell for the same sort of story from UCM in Aussie...Lucky to get out with my capital intact.
For fun look at their 2 year chart.
Perhaps they could merge.?
The product literally saves lives, Thats a pretty good reason to invest and get this product to market.
-
01-06-2023, 02:48 PM
#912
Originally Posted by HITMAN
The product literally saves lives, Thats a pretty good reason to invest and get this product to market.
Realy and how , show me the U S Medical ass verification via reputably medical journals ?
-
01-06-2023, 05:56 PM
#913
Member
Never argue with stupid people, they will drag you down to their level
and then beat you with experience.
- Mark Twain
-
05-07-2023, 08:28 AM
#914
Member
-
15-08-2023, 10:19 AM
#915
https://www.nzx.com/announcements/416386
Strong Sales growth in Q1 FY2024 (April to June 2023)
Highlights
• TruScreen experiences strong sales growth in Q1 FY24
• Product sales up 100% Q1 2024/Q1 2023 and SUS sales up 73% to 56,160 units for the quarter
• China continues to grow strongly with contributions from new Health Check sector
Truscreen Group Limited (NZX/ASX:TRU) is pleased to report a 100% growth in sales over the same quarter year on year and a 73% growth in sales of Single Use Sensor (SUS) for the same period.
China continues to drive the growth, and demand is returning to pre COVID levels. The commencement of the Health Check project which aims to screen 10,000 women in the next 3 years also contributed to the sales growth.
The endorsement of TruScreen's AI-enabled technology in the latest edition of CSCCP's China Cervical Cancer Screening Guideline, published in the July 2023 edition of CSCCP's journal, Chinese Journal of Clinical Gynaecology and Obstetrics, and the recent endorsement in the prestigious Blue Book in China, are enabling our distributor Siweixiangtai Tech Co. Ltd (SWXT) to capitalise on the rapid growth in demand.
The CEO, Dr Beata Edling commented:
“I am delighted to report on our Q1 results. A recent trip to Asia and Eastern Europe has confirmed that our efforts in co-investing with our committed distributors are paying off and that the distributors are poised to capture the rapid growth in demand for TruScreen’s technology.
We have invested considerable resources in developing Vietnam, Saudi Arabia and Zimbabwe, and expect that our distributors will broaden our installed base of TruScreen business in their regions in the coming years”.
This announcement has been approved by the Board.
-
15-08-2023, 11:18 AM
#916
Member
China continues to drive the growth, and demand is returning to pre COVID levels. The commencement of the Health Check project which aims to screen 10,000 women in the next 3 years also contributed to the sales growth.
500,000,000 women over the age of 15.
10,000 women over 3 years(!) involved in health project
Might be early days for the project but I feel the govt should cherish the health of their people a little more
-
15-08-2023, 11:22 AM
#917
Member
China continues to drive the growth, and demand is returning to pre COVID levels. The commencement of the Health Check project which aims to screen 10,000 women in the next 3 years also contributed to the sales growth.
3,333 SUS a year
833 SUS a quarter
This isn't going be a driver in growth for the 3 year time frame
-
15-08-2023, 11:49 AM
#918
Member
Originally Posted by sunnysleeper11
China continues to drive the growth, and demand is returning to pre COVID levels. The commencement of the Health Check project which aims to screen 10,000 women in the next 3 years also contributed to the sales growth.
3,333 SUS a year
833 SUS a quarter
This isn't going be a driver in growth for the 3 year time frame
Yes, they have reported this before in a release...
The private health check-up project aims to screen 10,000 women across 10 centres in 3-6 months.
Maybe an error.
Very happy to see sales growth of 100% for the quarter.
-
15-08-2023, 12:16 PM
#919
Originally Posted by Sideshow Bob
https://www.nzx.com/announcements/416386
Strong Sales growth in Q1 FY2024 (April to June 2023)
Highlights
• TruScreen experiences strong sales growth in Q1 FY24
• Product sales up 100% Q1 2024/Q1 2023 and SUS sales up 73% to 56,160 units for the quarter
• China continues to grow strongly with contributions from new Health Check sector
Truscreen Group Limited (NZX/ASX:TRU) is pleased to report a 100% growth in sales over the same quarter year on year and a 73% growth in sales of Single Use Sensor (SUS) for the same period.
China continues to drive the growth, and demand is returning to pre COVID levels. The commencement of the Health Check project which aims to screen 10,000 women in the next 3 years also contributed to the sales growth.
The endorsement of TruScreen's AI-enabled technology in the latest edition of CSCCP's China Cervical Cancer Screening Guideline, published in the July 2023 edition of CSCCP's journal, Chinese Journal of Clinical Gynaecology and Obstetrics, and the recent endorsement in the prestigious Blue Book in China, are enabling our distributor Siweixiangtai Tech Co. Ltd (SWXT) to capitalise on the rapid growth in demand.
The CEO, Dr Beata Edling commented:
“I am delighted to report on our Q1 results. A recent trip to Asia and Eastern Europe has confirmed that our efforts in co-investing with our committed distributors are paying off and that the distributors are poised to capture the rapid growth in demand for TruScreen’s technology.
We have invested considerable resources in developing Vietnam, Saudi Arabia and Zimbabwe, and expect that our distributors will broaden our installed base of TruScreen business in their regions in the coming years”.
This announcement has been approved by the Board.
really, hard to believe imo.
-
15-08-2023, 01:50 PM
#920
Member
Trying to find anyone who wanted your opinion… crickets…
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks